Genesis Healthcare Inc. (GEN)

1.59
0.04 2.90
NYSE : Health Services
Prev Close 1.55
Open 1.54
Day Low/High 1.52 / 1.61
52 Wk Low/High 0.60 / 2.68
Volume 223.12K
Avg Volume 717.90K
Exchange NYSE
Shares Outstanding 97.22M
Market Cap 277.58M
EPS -6.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Genesis HealthCare Raises Over $222,000 As A Gold Level National Team For Alzheimer's Association Walk To End Alzheimer's®

Genesis HealthCare Raises Over $222,000 As A Gold Level National Team For Alzheimer's Association Walk To End Alzheimer's®

Walk to End Alzheimer's is Largest Fundraiser Dedicated to Alzheimer's Care, Support and Research Programs

Felicia Chew Of Genesis Rehab Services Approved As Co-Principal Investigator In $4.7 Million Funding Award

Felicia Chew Of Genesis Rehab Services Approved As Co-Principal Investigator In $4.7 Million Funding Award

Contract funded by the Patient-Centered Outcomes Research Institute to Study Treatment Approaches for Nursing Home Residents with Dementia

Genmab And Seattle Genetics To Initiate New Study Of Novel Antibody-Drug Conjugate Tisotumab Vedotin In Cervical Cancer

Genmab And Seattle Genetics To Initiate New Study Of Novel Antibody-Drug Conjugate Tisotumab Vedotin In Cervical Cancer

Genmab A/S (Nasdaq Copenhagen: GEN) and Seattle Genetics, Inc. (NASDAQ: SGEN) announced today a decision to start a Phase II study of tisotumab vedotin in patients with recurrent and/or metastatic cervical cancer.

Short Interest Expands By 29.6% For GEN

Short Interest Expands By 29.6% For GEN

The most recent short interest data has been released for the 09/15/2017 settlement date, which shows a 657,491 share increase in total short interest for Genesis Healthcare Inc , to 2,874,971, an increase of 29.65% since 08/31/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Genesis Rehab Services Honored By Philadelphia Business Journal As A 2017 Health Care Innovator

Genesis Rehab Services Honored By Philadelphia Business Journal As A 2017 Health Care Innovator

Awards program recognizes region's most innovative companies and doctors

Genesis HealthCare Opens 11th PowerBack Rehabilitation Location

Genesis HealthCare Opens 11th PowerBack Rehabilitation Location

3rd PowerBack Rehabilitation Location in New Jersey

Genmab And Seattle Genetics To Co-develop Tisotumab Vedotin For Solid Tumors

Genmab And Seattle Genetics To Co-develop Tisotumab Vedotin For Solid Tumors

Genmab A/S (Nasdaq Copenhagen: GEN) and Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that Seattle Genetics, Inc.

Eight Genesis HealthCare Centers Receive Silver National Quality Award 

Eight Genesis HealthCare Centers Receive Silver National Quality Award 

Centers recognized by national program for commitment to quality care

Six Genesis HealthCare Centers Receive Bronze National Quality Award

Centers recognized by national program for commitment to quality care

TheStreet Quant Rating: D (Sell)